M
Monopar Therapeutics (MNPR)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Monopar Therapeutics (MNPR)
Monopar Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on the development of therapeutics designed to extend life or improve the quality of life for cancer patients. The Company's pipeline consists of Validive, camsirubicin, ... Read more
- USD44.90
- USD44.90
- USD40.72
- USD54.30
- 7.40%
- --
- 25.19k
- 242M
- 1.72
- 1.26k%
Stock News
yesterday
Whirlpool says it’s a ‘winner’ under new tariffs, as consumers stay cautious
MarketWatch
yesterday
GE Vernova CEO says current U.S. demand for electricity is the largest since the end of WWII
CNBC
yesterday
Alaska Airlines warns of slower demand as second-quarter profit outlook falls short
CNBC
yesterday
Brookline: Q1 Earnings Snapshot
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
